0001209191-23-058458.txt : 20231213 0001209191-23-058458.hdr.sgml : 20231213 20231213134019 ACCESSION NUMBER: 0001209191-23-058458 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231212 FILED AS OF DATE: 20231213 DATE AS OF CHANGE: 20231213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Quinn William P. CENTRAL INDEX KEY: 0001724190 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39988 FILM NUMBER: 231483587 MAIL ADDRESS: STREET 1: SUNESIS PHARMACEUTICALS, INC. STREET 2: 395 OYSTER POINT BOULEVARD, SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bolt Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001641281 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472804636 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-665-9295 MAIL ADDRESS: STREET 1: 900 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 FORMER COMPANY: FORMER CONFORMED NAME: Bolt Therapeutics, Inc. DATE OF NAME CHANGE: 20150504 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-12-12 0 0001641281 Bolt Biotherapeutics, Inc. BOLT 0001724190 Quinn William P. C/O BOLT BIOTHERAPEUTICS, INC. 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 0 1 0 0 Chief Financial Officer 0 Common Stock 2023-06-06 4 P 0 1829 1.1815 A 26272 D Common Stock 2023-12-06 4 P 0 2500 0.782 A 28772 D Common Stock 2023-12-12 4 P 0 7500 0.95 A 36272 D Shares acquired under the issuer's Employee Stock Purchase Plan. /s/ William P. Quinn 2023-12-13